Lionsgate Studios Corp.
US ˙ NYSE ˙ US316041CP59

SecurityLION / Lionsgate Studios Corp.
InsiderMHR Institutional Advisors III LLC
This page shows the track record and history of MHR Institutional Advisors III LLC insider trades in Lionsgate Studios Corp.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by MHR Institutional Advisors III LLC in LION / Lionsgate Studios Corp.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2011-08-29 11,040,493 7.0000 11,040,493 7.0000 77,283,451 731
2011-01-07 819,823 6.5000 819,823 6.5000 5,328,850
2009-03-10 360,000 5.3337 360,000 5.3337 1,920,132
2009-03-06 19,000 5.1239 19,000 5.1239 97,354
2009-03-06 150,000 5.1500 150,000 5.1500 772,500
2009-03-05 300 5.0000 300 5.0000 1,500
2009-03-05 199,054 5.1229 199,054 5.1229 1,019,734

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LION / Lionsgate Studios Corp. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by MHR Institutional Advisors III LLC in LION / Lionsgate Studios Corp.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2015-11-10 426,336 39.0200 426,336 39.0200 16,635,631 87
2015-11-10 61,771 39.0200 61,771 39.0200 2,410,304
2015-11-10 458,864 39.0200 458,864 39.0200 17,904,873
2015-11-10 1,156,015 39.0200 1,156,015 39.0200 45,107,705
2015-11-10 7,861,014 39.0200 7,861,014 39.0200 306,736,766
2015-04-29 48,584 31.6000 48,584 31.6000 1,535,254
2015-04-29 6,491 31.6000 6,491 31.6000 205,116
2015-04-29 48,220 31.6000 48,220 31.6000 1,523,752
2015-04-29 121,480 31.6000 121,480 31.6000 3,838,768
2015-04-29 826,075 31.6000 826,075 31.6000 26,103,970
2015-04-13 462,336 31.6000 462,336 31.6000 14,609,818
2015-04-13 61,771 31.6000 61,771 31.6000 1,951,964
2015-04-13 458,864 31.6000 458,864 31.6000 14,500,102
2015-04-13 1,156,015 31.6000 1,156,015 31.6000 36,530,074
2015-04-13 7,861,014 31.6000 7,861,014 31.6000 248,408,042

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LION / Lionsgate Studios Corp. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class A Voting Shares J - Other I 11,874,474 11,874,474
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class B Non-Voting Shares J - Other I 11,874,474 11,874,474
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Common Shares J - Other I -23,748,947 0
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class A Voting Shares J - Other I 1,746,222 1,746,222
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class B Non-Voting Shares J - Other I 1,746,222 1,746,222
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Common Shares J - Other I -3,492,443 0
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class A Voting Shares J - Other I 693,138 693,138
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class B Non-Voting Shares J - Other I 693,138 693,138
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Common Shares J - Other I -1,386,275 0
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class A Voting Shares J - Other I 93,309 93,309
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class B Non-Voting Shares J - Other I 93,309 93,309
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Common Shares J - Other I -186,617 0
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class A Voting Shares J - Other I 698,384 698,384
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Class B Non-Voting Shares J - Other I 698,384 698,384
2016-12-12 2016-12-08 4 RACHESKY MARK H MD See Footnotes LGF Common Shares J - Other I -1,396,767 0
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Class A Voting Shares J - Other D 432 432
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Class B Non-Voting Shares J - Other D 432 432
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Common Shares J - Other D -865 0
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Class A Voting Shares J - Other D 253 253
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Class B Non-Voting Shares J - Other D 253 253
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Common Shares J - Other D -507 0
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Class A Voting Shares J - Other D 1,221 1,221
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Class B Non-Voting Shares J - Other D 1,221 1,221
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Common Shares J - Other D -2,443 0
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Class A Voting Shares J - Other D 31,137 31,137
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Class B Non-Voting Shares J - Other D 31,137 31,137
2016-12-12 2016-12-08 4 RACHESKY MARK H MD LGF Common Shares J - Other D -62,274 0
2015-11-13 2015-11-10 4 RACHESKY MARK H MD LGF Common Shares S - Sale I 39.0200 -7,861,014 -306,737 23,748,947
2015-11-13 2015-11-10 4 RACHESKY MARK H MD LGF Common Shares S - Sale I 39.0200 -1,156,015 -45,108 3,492,443
2015-11-13 2015-11-10 4 RACHESKY MARK H MD LGF Common Shares S - Sale I 39.0200 -458,864 -17,905 1,386,275
2015-11-13 2015-11-10 4 RACHESKY MARK H MD LGF Common Shares S - Sale I 39.0200 -61,771 -2,410 186,617
2015-11-13 2015-11-10 4 RACHESKY MARK H MD LGF Common Shares S - Sale I 39.0200 -426,336 -16,636 1,396,767
2015-04-30 2015-04-29 4 RACHESKY MARK H MD See Footnotes LGF Common Shares S - Sale I 31.6000 -826,075 -26,104 31,609,961
2015-04-30 2015-04-29 4 RACHESKY MARK H MD See Footnotes LGF Common Shares S - Sale I 31.6000 -121,480 -3,839 4,648,458
2015-04-30 2015-04-29 4 RACHESKY MARK H MD See Footnotes LGF Common Shares S - Sale I 31.6000 -48,220 -1,524 1,845,139
2015-04-30 2015-04-29 4 RACHESKY MARK H MD LGF Common Shares S - Sale I 31.6000 -6,491 -205 248,388
2015-04-30 2015-04-29 4 RACHESKY MARK H MD See Footnotes LGF Common Shares S - Sale I 31.6000 -48,584 -1,535 1,859,103
2015-04-14 2015-04-13 4 RACHESKY MARK H MD See Footnotes LGF Common Shares S - Sale I 31.6000 -7,861,014 -248,408 32,436,036
2015-04-14 2015-04-13 4 RACHESKY MARK H MD See Footnotes LGF Common Shares S - Sale I 31.6000 -1,156,015 -36,530 4,769,938
2015-04-14 2015-04-13 4 RACHESKY MARK H MD See Footnotes LGF Common Shares S - Sale I 31.6000 -458,864 -14,500 1,893,359
2015-04-14 2015-04-13 4 RACHESKY MARK H MD LGF Common Shares S - Sale I 31.6000 -61,771 -1,952 254,879
2015-04-14 2015-04-13 4 RACHESKY MARK H MD See Footnotes LGF Common Shares S - Sale I 31.6000 -462,336 -14,610 1,907,687
2011-08-31 2011-08-29 4 RACHESKY MARK H MD LGF Common Shares P - Purchase I 7.0000 11,040,493 77,283 40,297,050
2011-01-07 2011-01-07 4 RACHESKY MARK H MD LGF Common Shares P - Purchase I 6.5000 819,823 5,329 29,256,557
2010-07-21 2010-07-20 4 RACHESKY MARK H MD LGF 3.625% Convertible Senior Subordinated Notes Due 2027 C - Conversion I 6.20 0
2010-07-21 2010-07-20 4 RACHESKY MARK H MD LGF 2.9375% Convertible Senior Subordinated Notes Due 2026 C - Conversion I 6.20 0
2010-07-21 2010-07-20 4 RACHESKY MARK H MD LGF 3.625% Convertible Senior Subordinated Notes Due 2027 P - Purchase I 6.20 5,881,006
2010-07-21 2010-07-20 4 RACHESKY MARK H MD LGF 2.9375% Convertible Senior Subordinated Notes Due 2026 P - Purchase I 6.20 10,355,299
2010-07-21 2010-07-20 4 RACHESKY MARK H MD LGF Common Shares C - Conversion I 6.2000 5,881,006 36,462 28,436,734
2010-07-21 2010-07-20 4 RACHESKY MARK H MD LGF Common Shares C - Conversion I 6.2000 10,355,299 64,203 22,555,728
2009-03-11 2009-03-10 4 RACHESKY MARK H MD LGF Common Shares P - Purchase I 5.3337 360,000 1,920 12,200,429
2009-03-06 2009-03-06 4 RACHESKY MARK H MD LGF Common Shares P - Purchase I 5.1500 150,000 772 11,840,429
2009-03-06 2009-03-06 4 RACHESKY MARK H MD LGF Common Shares P - Purchase I 5.1239 19,000 97 11,690,429
2009-03-06 2009-03-05 4 RACHESKY MARK H MD LGF Common Shares P - Purchase I 5.1229 199,054 1,020 11,671,429
2009-03-06 2009-03-05 4 RACHESKY MARK H MD LGF Common Shares P - Purchase I 5.0000 300 2 11,472,375
2009-03-06 3 MHR Institutional Partners III LP See Footnotes LGF Common Shares I 11,840,429
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)